ARTICLE | Clinical News
Provir: Will begin Phase II trials in secretory diarrhea. Provir had been in testing for respiratory syncytial disease, but SHMN concluded that bioavailability
October 23, 1995 7:00 AM UTC
Shaman Pharmaceuticals Inc. (SHMN), South San Francisco Product: Provir (SP-303) Indication: Secretory (watery) diarrhea Status: Will begin Phase II trials in secretory diarrhea. Provir had been in te...